Velleca Mark A. 4
4 · Black Diamond Therapeutics, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
Velleca Mark A.
DirectorPRESIDENT & CEO
Transactions
- Award
Common Stock
2023-03-16$1.67/sh+11,228$18,751→ 32,385 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 16, 2023.